Usha L. Katari

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Transforming Growth Factor-β Signaling in Immunity and Cancer

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Delivery technologies for cancer immunotherapy

Tuberculosis and lung damage: from epidemiology to pathophysiology

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Nasopharyngeal carcinoma

CAR T‐cell immunotherapy: The path from the by‐road to the freeway?

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

CAR-T cell therapy: current limitations and potential strategies

Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients

Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells

A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer

Design and development of therapies using chimeric antigen receptor‐expressing T cells

Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma

Engineered T cells for pancreatic cancer treatment

Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT